Mannkind (MNKD) Non Operating Income (2010 - 2026)
Mannkind (MNKD) reported Non Operating Income of -$14.7 million for Q1 2026, down 69.42% year-over-year from -$48.1 million in Q1 2025, and down 163.52% on a QoQ basis from $23.1 million in Q4 2025.
Mannkind (MNKD) has 17 years of Non Operating Income data on file, last reported at -$14.7 million in Q1 2026.
- Quarterly Non Operating Income fell 69.42% year-over-year to -$14.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.0 million (down 149.72% YoY) and the FY2025 annual result came in at -$1.0 million, down 3253.12% from the prior year.
- Non Operating Income retreated to -$14.7 million in Q1 2026 per MNKD's latest filing, from $23.1 million in the prior quarter.
- Across five years, Non Operating Income topped out at $24.1 million in Q4 2024 and bottomed at -$19.3 million in Q4 2023.
- The 5-year median for Non Operating Income is -$4.7 million (2022), against an average of -$3.2 million.
- The widest annual swing landed in 2022, when Non Operating Income tumbled 24582.86%; it then soared 253.62% in 2023.
- Tracing MNKD's Non Operating Income over 5 years: stood at $105000.0 in 2022, then tumbled by 18520.0% to -$19.3 million in 2023, then surged by 224.35% to $24.1 million in 2024, then retreated by 3.78% to $23.1 million in 2025, then tumbled by 163.52% to -$14.7 million in 2026.
- Per Business Quant, the three latest MNKD Non Operating Income figures stand at -$14.7 million (Q1 2026), $23.1 million (Q4 2025), and -$11.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 444,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 201.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -46.98 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | -14.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.70 Mn |
| Dec 31, 2025 | 23.14 Mn |
| Sep 30, 2025 | -11.12 Mn |
| Jun 30, 2025 | -4.36 Mn |
| Mar 31, 2025 | -8.68 Mn |
| Dec 31, 2024 | 24.05 Mn |
| Sep 30, 2024 | 110,000.00 |
| Jun 30, 2024 | -18.30 Mn |
| Mar 31, 2024 | -5.83 Mn |
| Dec 31, 2023 | -19.34 Mn |
| Sep 30, 2023 | 318,000.00 |
| Jun 30, 2023 | -6.99 Mn |
| Mar 31, 2023 | 111,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | -207,000.00 |
| Jun 30, 2022 | -8.57 Mn |
| Mar 31, 2022 | -4.74 Mn |
| Dec 31, 2021 | -33.66 Mn |
| Sep 30, 2021 | 1,000.00 |
| Jun 30, 2021 | 35,000.00 |
| Mar 31, 2021 | -276,000.00 |
| Dec 31, 2020 | -2.66 Mn |
| Sep 30, 2020 | 14,000.00 |
| Jun 30, 2020 | -2.34 Mn |
| Mar 31, 2020 | -4,000.00 |
| Dec 31, 2019 | -7.22 Mn |
| Sep 30, 2019 | -1.59 Mn |
| Jun 30, 2019 | -1.44 Mn |
| Mar 31, 2019 | -1.37 Mn |
| Dec 31, 2018 | -10.21 Mn |
| Sep 30, 2018 | 10,000.00 |
| Jun 30, 2018 | -1.90 Mn |
| Mar 31, 2018 | 31,000.00 |
| Dec 31, 2017 | -9.11 Mn |
| Sep 30, 2017 | -4.71 Mn |
| Jun 30, 2017 | -3.77 Mn |
| Mar 31, 2017 | 3.28 Mn |
| Dec 31, 2016 | 59.02 Mn |
| Sep 30, 2016 | 8.29 Mn |
| Jun 30, 2016 | -653,000.00 |
| Mar 31, 2016 | 67,000.00 |
| Dec 31, 2015 | -104,000.00 |
| Sep 30, 2015 | 67,000.00 |
| Jun 30, 2015 | -10,000.00 |
| Mar 31, 2015 | 1.41 Mn |
| Dec 31, 2014 | 41,000.00 |
| Sep 30, 2014 | 7.90 Mn |
| Jun 30, 2014 | -370,000.00 |
| Mar 31, 2014 | -5.89 Mn |
| Dec 31, 2013 | -683,000.00 |
| Sep 30, 2013 | 10,000.00 |
| Jun 30, 2013 | 15,000.00 |
| Mar 31, 2013 | 23,000.00 |
| Dec 31, 2012 | -13.27 Mn |
| Sep 30, 2012 | -2.65 Mn |
| Jun 30, 2012 | 13.35 Mn |
| Mar 31, 2012 | 1.38 Mn |
| Dec 31, 2011 | 65,000.00 |
| Sep 30, 2011 | 79,000.00 |
| Jun 30, 2011 | 47,000.00 |
| Mar 31, 2011 | 1.35 Mn |
| Dec 31, 2010 | -627,000.00 |
| Sep 30, 2010 | 1.95 Mn |
| Jun 30, 2010 | -1.26 Mn |